AVDEX
Price
$12.81
Change
-$0.12 (-0.93%)
Updated
Sep 20 closing price
VTSNX
Price
$135.52
Change
-$1.58 (-1.15%)
Updated
Sep 20 closing price
Ad is loading...

AVDEX vs VTSNX

Header iconAVDEX vs VTSNX Comparison
Open Charts AVDEX vs VTSNXBanner chart's image
Avantis® International Equity Instl
Price$12.81
Change-$0.12 (-0.93%)
VolumeN/A
CapitalizationN/A
Vanguard Total Intl Stock Index I
Price$135.52
Change-$1.58 (-1.15%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
AVDEX vs VTSNX Comparison Chart
Loading...
VS
AVDEX vs. VTSNX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVDEX is a StrongBuy and VTSNX is a Buy.

FUNDAMENTALS
Fundamentals
VTSNX has more cash in the bank: 453B vs. AVDEX (256M). VTSNX pays higher dividends than AVDEX: VTSNX (3.29) vs AVDEX (3.01). AVDEX was incepted earlier than VTSNX: AVDEX (5 years) vs VTSNX (14 years). AVDEX is a more actively managed with annual turnover of: 7.00 vs. VTSNX (4.00). AVDEX (5000000) and VTSNX (5000000) have matching initial minimum investment requirements. AVDEX annual gain was more profitable for investors over the last year : 17.63 vs. VTSNX (14.36).
AVDEXVTSNXAVDEX / VTSNX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence5 years14 years-
Gain YTD10.3578.245126%
Front LoadN/AN/A-
Min. Initial Investment50000005000000100%
Min. Initial Investment IRAN/AN/A-
Net Assets256M453B0%
Annual Yield % from dividends3.013.2992%
Returns for 1 year17.6314.36123%
Returns for 3 years10.12-1.37-738%
Returns for 5 yearsN/A24.19-
Returns for 10 yearsN/A29.05-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GEHC88.531.74
+2.00%
GE HealthCare Technologies
MATX132.361.05
+0.80%
Matsons
WEYS33.72-0.14
-0.41%
Weyco Group
HE12.06-0.18
-1.47%
Hawaiian Electric Industries
OKYO1.03-0.03
-2.42%
OKYO Pharma Limited